Biotech company Seelos Therapeutics, Inc. (Nasdaq: SEEL) told investors on Tuesday that its drug SLS-005 (IV trehalose) failed a study...
The JAMA (Journal of American Medical Association) Psychiatry published an article calling for more research and surveillance of ketamine treatments. Citing...
New potential therapies like MDMA will need more infrastructure beyond just buildings. The post Prepping the psychedelic industry for MDMA approval appeared...
Wall Street's latest fresh record highs last week were driven by four, not seven magnificent tech stock performances. So who's ... Read More The post TECH...
Whether you are taking a solo journey or spending a weekend in ceremony, knowing how to prepare for a psychedelic trip is invaluable to the outcome.
Psychedelic Invest publishes its annual psychedelics industry report summarizing all of the events of 2023.
The Psychedelic Education Market is Expanding Rapidly This rapid expansion is occurring in response to growth— both real and perceived- in the greater...
The psychedelics industry has huge potential shackled by uncertainty. The post What’s in store for psychedelics in 2024 appeared first on Green Market...
Booty bumping may sound like a fun way to party, but boofing ketamine comes with some hefty risks.
The founder of TOMS has taken interest, too. The post Tara Mind attracts $8M to bring ketamine therapy to workplace benefits appeared first on Green Market...